Disseminated coagulopathy in chronic myelomonocytic leukemia.
The clinical and laboratory features of nine patients with chronic myelomonocytic leukemia are described. Hepatic or splenic enlargement accompanied by an absolute monocytosis in an older patient with an elevated serum or urine lysozyme and serum vitamin B12 levels were characteristic of the majority of patients in this series. No single clinical or laboratory finding was diagnostic for the disease. Most importantly, seven of nine patients had abnormal coagulation values; in two cases the abnormalities were consistent with disseminated intravascular coagulation and correlated with a hemorrhagic diathesis. It is concluded that patients with chronic myelomonocytic leukemia who have thrombocytopenia or a bleeding tendency should be evaluated for evidence of disseminated intravascular coagulation.
D000368:Aged; D001853:Bone Marrow / Q000473:pathology; D004211:Disseminated Intravascular Coagulation / Q000150:complications* / Q000175:diagnosis; D005260:Female; D006529:Hepatomegaly; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000473:pathology; D009113:Muramidase / Q000032:analysis; D013163:Splenomegaly; D014805:Vitamin B 12 / Q000097:blood
D009113:Muramidase; D014805:Vitamin B 12